Patient Guide: A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 31 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05197426
Status: ACTIVE_NOT_RECRUITING
Condition: Acute Myeloid Leukemia
Phase: PHASE2

Where You Can Participate

This study is available at 31 locations across the country.

Top locations include:
  • • Huntsville, Alabama
  • • Nagoya, Aichi-ken
  • • Nagoya, Aichi-ken
  • • And 28 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission - Join Clinical Trial NCTNCT05197426

How to Join This Clinical Trial - NCTNCT05197426

Learn how to participate in this PHASE2 trial studying an investigational therapy for Acute Myeloid Leukemia. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Myeloid Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Myeloid Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05197426 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 31 locations. Find a study site near you:

Clinical Research Site

Huntsville, Alabama 35801 - United States

Status: Contact for availability

Clinical Research Site

Nagoya, Aichi-ken 453-8511 - Japan

Status: Contact for availability

Clinical Research Site

Nagoya, Aichi-ken 4668560 - Japan

Status: Contact for availability

Clinical Research Site

Toyoake, Aichi-ken 470-1192 - Japan

Status: Contact for availability

Clinical Research Site

Aomori, Aomori 0308553 - Japan

Status: Contact for availability

Clinical Research Site

Kamogawa, Chiba 2968602 - Japan

Status: Contact for availability

Clinical Research Site

Kashiwa-shi, Chiba 2778577 - Japan

Status: Contact for availability

Clinical Research Site

Matsuyama, Ehime 7900826 - Japan

Status: Contact for availability

Clinical Research Site

Yoshida Gun, Fukui 9101193 - Japan

Status: Contact for availability

Clinical Research Site

Fukuoka, Fukuoka 810-8539 - Japan

Status: Contact for availability

And 21 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Acute Myeloid Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships